Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1132159 | 0.73 | — | — | |
| Alcohol SCHEMBL28098867 | 0.73 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL15561070 | 0.73 | MEN1 (0.33) | MEN1LMNAKMT2ATSHR | |
| SCHEMBL31531230 | 0.72 | — | — | |
| SCHEMBL7788961 | 0.71 | — | — | |
| SCHEMBL589867 | 0.71 | — | — | |
| SCHEMBL8950565 | 0.71 | — | — | |
| SCHEMBL589868 | 0.71 | — | — | |
| SCHEMBL440679 | 0.69 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL2481172 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 494 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117534577-B | Tertiary esteramine and continuous process for preparing same | 成都惠恩精细化工有限责任公司 | 2026-05-19 | — | — | CN | claimed |
| US-12606566-B2 | Substituted cyclopenta[4,5]pyrrolo[1,2-a]pyrazines as bruton's tyrosine kinase inhibitors | SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD. (CN) | 2026-04-21 | — | — | US | claimed |
| CN-118538468-A | Preparation method of metal slurry for low-temperature co-firing | 安徽蓝讯通信科技有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-113039039-B | Polishing composition and method of use thereof | 富士胶片电子材料美国有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118222349-A | Demoulding component with function of reinforcing concrete surface layer and preparation method thereof | 中建西部建设新疆有限公司 | 2024-06-21 | — | — | CN | claimed |
| EP-4356737-A2 | BIOCIDE | Purgos ApS (DK) | 2024-04-24 | — | — | EP | claimed |
| CN-117863615-A | Production process of storage battery shell using carbon fiber composite lightweight material | 宁波科德新能源科技有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117627579-A | Construction method for temporary plugging string detection of pressurized water injection well | 中国石油天然气集团有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116731377-B | Antistatic sponge prepared from single-walled carbon nanotubes and preparation method thereof | 广东省多普达高新科技材料有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-117534577-A | Tertiary esteramine and continuous process for preparing same | 成都惠恩精细化工有限责任公司 | 2024-02-09 | — | — | CN | claimed |
| US-20060251743-A1 | Composition for inducing sleep comprising essential oils as active ingredients, a percutaneous pharmaceutical agent comprising thereof, and a process for producing thereof | NATURE TECHNOLOGY INC. (JP) | 2006-11-09 | — | — | US | claimed |
| US-20060166809-A1 | Methods for preparing catalysts | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2006-07-27 | — | — | US | claimed |
| US-20060100300-A1 | Toner composition | XEROX CORPORATION | 2006-05-11 | — | — | US | claimed |
| US-5840785-A | DEBINDING REACTION INJECTION MOLDING REACTION WITH METAL POWDERS AND IMPROVED RHEOLOGY | MEGAMET INDUSTRIES (US) | 1998-11-24 | — | — | US | claimed |
| WO-1997037789-A1 | MOLDING PROCESS FEEDSTOCK USING A COPPER TRIFLATE CATALYST | MEGAMET INDUSTRIES (US) | 1997-10-16 | — | — | WO | claimed |
| US-5403689-A | Amide functionality | XEROX CORPORATION (US) | 1995-04-04 | — | — | US | claimed |
| EP-0387119-B1 | Process for the condensation of at least one epoxide with at least one cyclic anhydride in the presence of a catalyst based on at least one nitrogen containing titanium complex | INST FRANCAIS DU PETROLE (FR) | 1993-11-18 | — | — | EP | claimed |
| US-5030711-A | Process for condensing at least one epoxide on at least one cyclic anhydride in the presence of a catalyst consisting of at least one titanium nitrogenous complex | INSTITUT FRANCAIS DU PETROLE (FR) | 1991-07-09 | — | — | US | claimed |
| EP-0387119-A2 | Process for the condensation of at least one epoxide with at least one cyclic anhydride in the presence of a catalyst based on at least one nitrogen containing titanium complex | Institut Français du Pétrole (FR) | 1990-09-12 | — | — | EP | claimed |
| US-4718987-A | BENZOATE | BERG LLOYD (US) | 1988-01-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606566-B2 | Substituted cyclopenta[4,5]pyrrolo[1,2-a]pyrazines as bruton's tyrosine kinase inhibitors | BTK, LYN, SYK | MEN1 2418/4885LMNA 3141/4885KMT2A 2652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.